Portea Medical Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 07-07-2024
- Paid Up Capital ₹ 0.20 M
as on 07-07-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -4973.50%
(FY 2022)
- Ebitda -29.91%
(FY 2022)
- Net Worth -36.01%
(FY 2022)
- Total Assets -60.05%
(FY 2022)
About Portea Medical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Meena Ganesh and Vaibhav Tewari serve as directors at the Company.
- CIN/LLPIN
U85100KA2012PTC102263
- Company No.
102263
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Portea Medical Private Limited offer?
Portea Medical Private Limited offers a wide range of products and services, including Farming Tools, Equipment & Machines, Disinfectant Sprayers, Medical & Surgical Clothing, OT Linen, Medical Consultants & Clinics, Health Care Service, Medical Consultancy Services, Physiotherapy Consultants, Health Club Services, Fitness Club.
Who are the key members and board of directors at Portea Medical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaibhav Tewari  | Director | 15-Sep-2014 | Current |
| Meena Ganesh | Director | 15-Sep-2014 | Current |
Financial Performance and Corporate Structure Insights of Portea Medical.
Portea Medical Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 4973.5% decrease in profit. The company's net worth observed a substantial decline by a decrease of 36.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Portea Medical?
In 2022, Portea Medical had a promoter holding of 100.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Portea Medical?
Portea Medical has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Portea Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Portea Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
